INOVIO PHARMACEUTICALS, INC. (INO) Operating income 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) annual operating income history from SEC filings — each fiscal year as reported.
-$86.8MFY2025 · since FY2016: -$76.2M → -$86.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.8M | +22.8% |
| FY2024 | -$112.4M | +21.9% |
| FY2023 | -$143.9M | +46.2% |
| FY2022 | -$267.6M | +11.2% |
| FY2021 | -$301.2M | -142.8% |
| FY2020 | -$124.1M | -11.7% |
| FY2019 | -$111.1M | -18.1% |
| FY2018 | -$94.1M | -12.5% |
| FY2017 | -$83.6M | -9.7% |
| FY2016 | -$76.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice